Frontlight ResearchEarly access
Taking people in United StatesNo phase
The MIRROR Registry: Minimally Invasive IntRaceRebral HemORrhage Evacuation
Key facts
- Who runs it
- Integra LifeSciences Corporation
- Where
- Baltimore, Buffalo, Burbank, Chapel Hill, Chicago, Cleveland, Columbia, Edison, Grand Rapids, Greenville, Hershey, Houston, Miami, New York, Oklahoma City, Philadelphia, Salt Lake City, Seattle, St Louis, and Tampa, United StatesSee the 20 sites
- Trial code
- Status
- Recruiting
- People taking part
- 500 people, planned
- Started
- 23 Oct 2020
- Expected to end
- 15 Oct 2029
- Type of study
- Observational
- Treatments tested
- Aurora Surgiscope System
- Record updated
- 6 February 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 15 criteriaShow less
Who can take part
- Subject Age is > 18
- Subject with a Head CT that demonstrates an acute, spontaneous, primary, supratentorial ICH of volume > 20 mL, assessed via standard of care techniques
- Subject Surgery can be initiated within 24 hours of the last known well time or, in patients with wake-up onset, within 24 hours of the time the patient awoke with symptoms
- Subject has a NIHSS score > 5
- Subject has a baseline Modified Rankin Scale (mRS) Score ≤ 2
- Subject with a CT Angiography demonstrating no vascular malformation
Who cannot take part
- Subject participates in another concurrent interventional clinical trial
- Subject has a mechanical heart valve
- Subject has an underlying vascular lesion defined as causative source of ICH
- Subject has a profound neurological deficit defined as fixed/dilated pupils or bilateral extensor motor posturing
- Subject has an Infratentorial or brainstem ICH
- Subject has a known life expectancy < 6 months
- Subject has an uncorrectable coagulopathy
- Subject is pregnant
- Subject who is unable to meet study follow-up requirements
Where in United States
- MedStar Health Research InstituteBaltimore, United StatesContact: Cynthia YashinkiNot yet recruiting
- University at BuffaloBuffalo, United StatesContact: Michaela LaskowskiTaking people
- Providence HealthBurbank, United StatesContact: Jeffrey FigueroaTaking people
- University of North CarolinaChapel Hill, United StatesContact: Patricia OrozcoTaking people
- Rush University Medical CenterChicago, United StatesContact: Rebecca McWilliamsTaking people
- Cleveland ClinicCleveland, United StatesContact: Joyce BarmenTaking people
- University of MissouriColumbia, United StatesContact: Brooke HoffmanTaking people
- JFK universityEdison, United StatesContact: Surekha Patel, MBBSTaking people
- Corewell HealthGrand Rapids, United StatesContact: Habib Nacer-ChérifNo longer taking part
- Prisma Health-UpstateGreenville, United StatesContact: Rosie GaddyTaking people
- Pennsylvania State UniversityHershey, United StatesContact: Olivia ChristmanTaking people
- UT HealthHouston, United StatesContact: Andrea GaitanNot yet recruiting
- University of MiamiMiami, United StatesContact: Adriana SaraviaTaking people
- Icahn School of Medicine at Mount SinaiNew York, United StatesContact: Emily SvendsenTaking people
- University of OklahomaOklahoma City, United StatesContact: Michael OminiTaking people
- University of PennsylvaniaPhiladelphia, United StatesContact: Habib Nacer-ChérifNo longer taking part
- University of UtahSalt Lake City, United StatesContact: Andrew Grandemange, MBATaking people
- University of Washington HarborviewSeattle, United StatesContact: Do LimTaking people
- Washington University in St. LouisSt Louis, United StatesContact: Ramie HeoTaking people
- University of South FloridaTampa, United StatesContact: Shardonnai SimsTaking people
About the trial
What the trial wants to find out
This registry will study the use of the Aurora® Surgiscope to provide surgical access and visualization in minimally invasive removal of hematoma in the brain. Many methods of hematoma removal are available and will be based on surgeon preference. The impact of patient selection and time to surgery from last known well time will be explored.
The group in the trial
- AURORA
Aurora® Surgiscope used for MIS evacuation of supratentorial hematoma
Treatment: Aurora Surgiscope System
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 6 February 2026